KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $1.2 million.

  • Evolent Health's Other Operating Expenses changed N/A to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.6 million, marking a year-over-year decrease of 103457.32%. This contributed to the annual value of -$18.9 million for FY2024, which is N/A changed from last year.
  • Evolent Health's Other Operating Expenses amounted to $1.2 million in Q3 2025.
  • Over the past 5 years, Evolent Health's Other Operating Expenses peaked at $392.1 million during Q2 2023, and registered a low of -$18.9 million during Q4 2024.
  • Moreover, its 5-year median value for Other Operating Expenses was $73000.0 (2021), whereas its average is $92.6 million.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first surged by 166669285.71% in 2022, then crashed by 100233.67% in 2024.
  • Evolent Health's Other Operating Expenses (Quarter) stood at $73000.0 in 2021, then skyrocketed by 353073.97% to $257.8 million in 2022, then plummeted by 99.19% to $2.1 million in 2023, then crashed by 1002.34% to -$18.9 million in 2024, then skyrocketed by 106.5% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, -$1.9 million for Q1 2025, and -$18.9 million during Q4 2024.